OTC · ENMI
DH Enchantment Inc.
$0.00$0.00 (0.0%)
DH Enchantment Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · PDMI · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Paradigm Medical Industries, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Paradigm Medical Industries, Inc. (PDMI) is a U.S.-based enterprise dedicated to the design, production, distribution, and sale of sophisticated medical instruments. These devices are primarily engineered for the timely diagnosis of glaucoma and a variety of other ocular conditions. The company's extensive product range addresses diverse ophthalmic diagnostic requirements. This includes biometric analyzers and A-scans like the P-2000 and P-2500 (which also function as pachymeters), along with P2700 and P37-II A/B scans. Paradigm also provides specialized blood flow analyzers, crucial for identifying and managing glaucoma and other retinal vascular disorders. Its offerings further extend to the P2200 pachymeter and the LD 500 and LD700 autoperimeters. For detailed corneal assessment, they feature the PARAVUE 300, suitable for both diagnostic imaging and contact lens fitting, and the SURVEYOR 500 for in-depth analysis of the cornea and anterior segment. The PARAMAX system, another key product, evaluates the functionality of ganglion cells to help identify individuals at risk of glaucoma. Additionally, Paradigm offers the P60 and P60 ACI ultrasound biomicroscopes, and the PARACAM 1000, a non-contact endothelial microscope. Complementing its hardware, the company also supplies essential software and various accessories. Paradigm Medical Industries was established in 1989 and operates from its headquarters in Salt Lake City, Utah.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
DH Enchantment Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Groove Botanicals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.43% below the high.
$0.00$0.00 (0.0%)
Indoor Harvest Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.46% below the high.
$0.00$0.00 (0.0%)
Forza Innovations Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
MedGen, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Lift & Co. Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (+40.0%)
T2 Biosystems, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.6% below the high.
$0.00$0.00 (0.0%)
Industry Source Consulting, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.0% below the high.
